Landos Biopharma (LABP) Announces Tim M. Mayleben to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. CRWV
2. NVDA
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. RXRX
10. SPCX

Go back to Landos Biopharma (LABP) Announces Tim M. Mayleben to Board

Landos Biopharma Announces the Appointment of Tim M. Mayleben to its Board of Directors

May 19, 2021 7:00 AM EDT

BLACKSBURG, Va., May 19, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc (NASDAQ: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced the appointment of Tim M. Mayleben to its Board of Directors. Mr. Mayleben joins Landos with more than 20 years of executive experience leading development activities as well as successfully spearheading clinical and business strategies within the life sciences industry.

We are pleased to introduce Tim as the newest Board member, Compensation Committee Chair and member of the Audit Committee, commented Josep Bassaganya-Riera,... More